BIO-UV Group reported a 31% rise in incomes from its maritime company sector, adding to full-year combined incomes of $56m for the 2022 fiscal year, verifying the sale of greater than 200 BIO-SEA ballast water therapy systems throughout the program of the year.
“2022 was another year of very strong growth for BIO-UV Group, for both the Land and Marine divisions,” stated Beno ît Gillmann, Founder, Chairman and also CHIEF EXECUTIVE OFFICER of BIO-UV Group.
“Ultimately, targets were exceeded with $1.6 million more in sales than the $54 million we had anticipated. This is well above the roadmap figure announced in 2018 at the time of the IPO.”
BIO-UV Group produces, supplies and also services BIO-SEA ballast water therapy systems for circulation prices varying from 13m3/h as much as 2100m3/h. The firm provides full turnkey BWTS solutions with setups on containerships, mass service providers, multi-cargo vessels, cruise liner, traveler ferryboats, offshore vessels, marine ships and also mega-yachts.
